Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Kestrel Therapeutics announced it raised $8 Million in an initial filing from an offering of $16 Million
PRIVATEFeb 21, 2025•over 1 year ago
Amount Raised
$8 Million
Round Type
Venture - Series Unknown
BostonBiotechnology
Company Information
Company
Kestrel Therapeutics
Location
Boston, Massachusetts, United States
About
Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS.
We rely on exceptional science, and our focus, always, is on patients.
Don't miss Kestrel Therapeutics's next move
Get an email the moment Kestrel Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts4 people are listed at Kestrel Therapeutics. We don't have their email yet.
Predictive Intelligence
Strategic
ML-powered predictions for Kestrel Therapeutics's next move